Double lung transplantation is better than single lung transplantation for end-stage chronic obstructive pulmonary disease: a meta-analysis
Background Lung transplantation is one of the most common treatment options for patients with end-stage chronic obstructive pulmonary disease. However, the choice between single and double lung transplantation for these patients remains a matter of debate. Therefore, we performed a systematic search of medical databases for studies on single lung transplantation, double lung transplantation, and chronic obstructive pulmonary disease. Methods The rate ratio and hazard ratio of survival were analyzed. The meta-analysis included 15 case–control and retrospective registry studies. Results The rate ratios of the 3-year survival (0.937 and P = 0.041) and 5-year survival (0.775 and P = 0.000) were lower for single lung transplantation than for double lung transplantation. However, the hazard ratio did not differ significantly between the two. Conclusions Double lung transplantation was found to provide better benefits than single lung transplantation in terms of the long-term survival in patients with chronic obstructive pulmonary disease..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Journal of cardiothoracic surgery - 19(2024), 1 vom: 30. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fang, Yu-Chi [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Chronic obstructive |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s13019-024-02654-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05535890X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05535890X | ||
| 003 | DE-627 | ||
| 005 | 20240402062320.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240402s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13019-024-02654-6 |2 doi | |
| 035 | |a (DE-627)SPR05535890X | ||
| 035 | |a (SPR)s13019-024-02654-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Fang, Yu-Chi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Double lung transplantation is better than single lung transplantation for end-stage chronic obstructive pulmonary disease: a meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background Lung transplantation is one of the most common treatment options for patients with end-stage chronic obstructive pulmonary disease. However, the choice between single and double lung transplantation for these patients remains a matter of debate. Therefore, we performed a systematic search of medical databases for studies on single lung transplantation, double lung transplantation, and chronic obstructive pulmonary disease. Methods The rate ratio and hazard ratio of survival were analyzed. The meta-analysis included 15 case–control and retrospective registry studies. Results The rate ratios of the 3-year survival (0.937 and P = 0.041) and 5-year survival (0.775 and P = 0.000) were lower for single lung transplantation than for double lung transplantation. However, the hazard ratio did not differ significantly between the two. Conclusions Double lung transplantation was found to provide better benefits than single lung transplantation in terms of the long-term survival in patients with chronic obstructive pulmonary disease. | ||
| 650 | 4 | |a Pulmonary disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Chronic obstructive |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lung transplantation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Proportional hazards models |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Registries |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Survival |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Meta-analysis |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Cheng, Wen-Hsin |4 aut | |
| 700 | 1 | |a Lu, Hung-I |4 aut | |
| 700 | 1 | |a Wang, Yi-Shi |4 aut | |
| 700 | 1 | |a Chuang, Kai-Hao |4 aut | |
| 700 | 1 | |a Lai, Hsing-Hua |4 aut | |
| 700 | 1 | |a Chen, Yu |4 aut | |
| 700 | 1 | |a Chen, Li-Chun |4 aut | |
| 700 | 1 | |a Tsai, Meng-Yun |4 aut | |
| 700 | 1 | |a Chang, Yu-Ping |4 aut | |
| 700 | 1 | |a Huang, Kuo-Tung |4 aut | |
| 700 | 1 | |a Lo, Chien-Ming |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiothoracic surgery |d BioMed Central, 2006 |g 19(2024), 1 vom: 30. März |w (DE-627)SPR02947129X |w (DE-600)2227224-0 |x 1749-8090 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g day:30 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13019-024-02654-6 |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2024 |e 1 |b 30 |c 03 | ||